 |
Recombinant humanized MAb 5c8 |
|---|---|
| Trade Name | |
| Orphan Indication | Prevention of rejection of pancreatic islet cell transplants |
| USA Market Approval | USA |
| USA Designation Date | 1999-03-22 00:00:00 |
| Sponsor | Biogen, Inc.;14 Cambridge Center;Cambridge, Massachusetts, 02142 |
